CD274 and neoplasm: On account of the complexity of the tumor immune microenvironment (TIME), the factors affecting the clinical effects of ICIs are multifaceted, including PD-L1 expression, tumor mutation burden (TMB), high microsatellite instability (MSI-H), gene expression profiles (GEPs), specific gene mutations, and several specific gut microbiomes (2, 5–9).